Total assets of Starry Pharmaceutical 2020-2022
In 2022, the Chinese pharmaceutical firm Starry Pharmaceutical possessed more than five billion yuan of total assets, mounting by 8.3 percent compared to the year prior. Although a relatively small company in the industry, Starry is one of the most important manufacturers of radiocontrast agents in China.